Hilde Jalving

Zoekresultaten

• 2024

  128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

  Hone Lopez, S., Loipfinger, S., Bhattacharya, A., Jalving, M., Oosting, S. F., Hiltermann, J., de Bruyn, M., de Vries, E. G. E., de Haan, J.-J. & Fehrmann, R., 14-sep.-2024, In: Annals of Oncology. 35, Supplement 2, blz. S266 1 blz.

  Onderzoeksoutput › Academic
• 2021

  (89)ZED88082A PET imaging to visualize CD8(+) T cells in patients with cancer treated with immune checkpoint inhibitor.

  de Ruijter, L. K., van de Donk, P. P., Hooiveld-Noeken, J. S., Giesen, D., Ungewickell, A., Fine, B. M., Williams, S. P., Bohorquez, S. M. S., Yadav, M., Koeppen, H., Jing, J., Guelman, S., Lin, M. T., Mamounas, M. J., Eastham, J., Kimes, P. K., Glaudemans, A. W., Brouwers, A. H., Lub-de Hooge, M. N. & Gietema, J. A. & 7 anderen, Schroder, C. P., Timens, W., Jalving, M., Elias, S., Oosting, S. F., de Groot, D. J. & de Vries, E. G., jul.-2021, In: Cancer Research. 81, 13, 2 blz.

  Onderzoeksoutput › Academic

• Manual versus artificial intelligence-based segmentations as a pre-processing step in whole-body dosimetry calculations

  van Sluis, J., Noordzij, W., De Vries, E. G., Kok, I. C., Jalving, M., Lub-de Hooge, N., Brouwers, A. H. & Boellaard, R., sep.-2021, In: European Journal of Nuclear Medicine and Molecular Imaging. 48, SUPPL 1, blz. S45-S45 1 blz.

  Onderzoeksoutput › Academic

• Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

  Oosting, S., Van der Veldt, A. A. M., GeurtsvanKessel, C. H., Fehrmann, R. S. N., Van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F. F., Hiltermann, T. J. N., Den Hartog, G., Jalving, M., Westphal, T., Battacharya, A., van der Heiden, M., Blank, C. U., Koopmans, M. P., van Els, C. A., Rots, N. Y., van Baarle, D., Haanen, J. B. A. G. & de Vries, E. G., sep.-2021, In: Annals of Oncology. 32, blz. S1337-S1337 1 blz.

  Onderzoeksoutput › Academic
• 2020

  Avelumab for Advanced Merkel Cell Carcinoma in the Netherlands; A Nationwide Survey

  Levy, S., Aarts, M. J. B., Eskens, F., Keymeulen, K. B. M., Been, L. B., GrUnhagen, D. J., van Akkooi, A. C. J., Jalving, M. & Tesselaar, M., mrt.-2020, In: Neuroendocrinology. 110, blz. 232-232 1 blz.

  Onderzoeksoutput › Academic

• Combined in vivo C-13-metabolomics and proteomics approach to optimise immunotherapy response in malignant melanoma.

  Evers, B., Gerding, A., Tiersma, J., van Eunen, K., Wolters, J. C., Reijngoud, D.-J., Jalving, M. & Bakker, B. M., dec.-2020, In: Cancer Research. 80, 23, 1 blz.

  Onderzoeksoutput › Academic

• Disparities in access to oncology clinical trials in Europe in the period 2009-2019

  Carneiro, A., Amaral, T. M. S., Brandao, M., Scheffler, M., Bol, K., Ferrara, R., Jalving, M., Lo Russo, G., Marquez-Rodas, I., Matikas, A., Mezquita, L., Morgan, G., Onesti, C. E., Pilotto, S., Saloustros, E. & Trapani, D., sep.-2020, In: Annals of Oncology. 31, blz. S1196-S1196 1 blz.

  Onderzoeksoutput › Academic

• First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

  Gelderblom, H., Gietema, J. A., Desar, I. M. E., Ajmone, N. M., Jalving, M., Kroep, J. R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S. F. & Damstrup, L., sep.-2020, In: Annals of Oncology. 31, blz. S501-S502 2 blz.

  Onderzoeksoutput › Academic

• Inhibition of glycogen degradation sensitizes glioblastoma cells to ionizing radiation

  Hendriks, A. M., Zois, C. E., Haider, S. B., Pires, E., Kalamida, D., Lagerholm, C., Morris, J., McCullagh, J. S., Fehrmann, R. S., den Dunnen, W. F., Harris, A. L. & Jalving, M., aug.-2020, In: Cancer Research. 80, 16, 2 blz.

  Onderzoeksoutput › Academic

• Targeting metabolism to improve response to immune-checkpoint inhibition in melanoma.

  Tiersma, J. F., Evers, B., Bakker, B. M., de Jong, S. & Jalving, M., dec.-2020, In: Cancer Research. 80, 23, 1 blz.

  Onderzoeksoutput › Academic

• The value of local therapy in treatment of solitary melanoma progression upon immune checkpoint inhibition

  Versluis, J. M., Hendriks, A. M., Weppler, A., Brown, L., de Joode, K., Suijkerbuijk, K. P. M., Zimmer, L., Kapiteijn, E., Allayous, C., Johnson, D. B., Hepner, A., Mangana, J., Bhave, P., Jansen, Y., Trojaniello, C., Atkinson, V., Storey, L., de Vries, E. G. E., Blank, C. U. & Jalving, M., sep.-2020, In: Annals of Oncology. 31, blz. S733-S734 2 blz.

  Onderzoeksoutput › Academic
• 2019

  Avelumab for advanced Merkel cell carcinoma in the Netherlands: A nationwide survey

  Levy, S., Aarts, M. J. B., Eskens, F. A., Keymeulen, K., Been, L., Grunhagen, D. J., van Akkooi, A. C. J., Jalving, M. & Tesselaar, M. E. T., okt.-2019, In: Annals of Oncology. 30, blz. 537-538 2 blz.

  Onderzoeksoutput › Academic

• Checkpoint inhibitor-induced colitis shares mucosal histopathological features with inflammatory bowel and graft-versus-host disease

  Hone Lopez, S., Kats-Ugurlu, G., Vries, L. D., Groot, M. D., Visschedijk, M., Jalving, M. & Haan, J. D., 1-jul.-2019, In: Cancer Research. 79, 13

  Onderzoeksoutput › Academic

  • Colitis 100%
  • Graft Versus Host Reaction 100%
  • Graft-Versus-Host Disease 100%
  • Inflammatory Bowel Disease 78%
  • Acute Graft Versus Host Disease 78%

• Cognitive concerns and performance in patients with metastatic non-small cell lung cancer (mnsclc)

  Eggen, A., Richard, N., Shen, G., Shultz, D., Leighl, N., Liu, G., Sun, A., Bosma, I., Reyners, A., Jalving, M., Rodin, G. & Edelstein, K., nov.-2019, In: Neuro-Oncology. 21, blz. 159 1 blz.

  Onderzoeksoutput › Academic

• Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

  Dieras, V. C., Han, H. S., Kaufman, B., Wildiers, H., Friedlander, M., Ayoub, J.-P., Puhalla, S. L., Bondarenko, I., Campone, M., Jakobsen, E. H., Jalving, M., Oprean, C., Palacova, M., Park, Y. H., Shparyk, Y., Yanez, E., Dudley, M., Ratajczak, C. K., Maag, D. & Arun, B. K., okt.-2019, In: Annals of Oncology. 30, blz. 857-858 2 blz.

  Onderzoeksoutput › Academic
• 2018

  PET segmentation of bulky tumors: inter-observer variability of four segmentation approaches

  Pfaehler, E., Burggraaff, C., Kramer, G., Zijlstra, J., Hoekstra, O., Jalving, M., Noordzij, W., Brouwers, A., Stevenson, M., de Jong, J. & Boellaard, R., 2018, In: European Journal of Nuclear Medicine and Molecular Imaging. 45, blz. S44 1 blz.

  Onderzoeksoutput › Academic

• Phase Ib study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer

  Broekman, K. E., Reyners, A. K. L., Touw, D. J., Hof, M. A. J. & Jalving, M., okt.-2018, In: Annals of Oncology. 29, Suppl_8, blz. 354-354 1 blz.

  Onderzoeksoutput › Academic

• The metabolic landscape browser: a novel tool for understanding pan-cancer metabolic processes through variance in gene expression data

  Leeuwenburgh, V., Bhattacharya, A., Urzua, C., Walvoort, M., Jalving, H., de Jong, S. & Fehrmann, R., nov.-2018, In: European Journal of Cancer. 103, Suppl.1, blz. E106-E106 1 blz., 318 (PB-079).

  Onderzoeksoutput › Academic

  Open Access

  Bestand
  1684 Downloads (Pure)
• 2017

  A subset of cutaneous melanomas contains high expression of genes related to oxidative phosphorylation determined using consensus clustering

  Wind, T. T., Jalving, M., De Haan, J., De Vries, E., Van Vugt, M., Reijngoud, D.-J., Van Rijn, R., Blank, C. U., Hospers, G. A. & Fehrmann, R., 1-jan.-2017, In: Pigment cell & melanoma research. 30, 1, blz. 151-152 2 blz.

  Onderzoeksoutput › Academic

  • Oxidative Phosphorylation 100%
  • Consensus Clustering 100%
  • P53 75%
  • Cell Cycle 75%
  • Gene Expression 50%

• Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards: A role for multidisciplinary molecular tumor boards

  ter Elst, A., 't Hart, N. A., van der Wekken, A. J., Timens, W., Hijmering-Kappelle, L. B., Hospers, G. A., Jalving, H., van der Logt, E. M., van Kempen, L. C., Oosting, S. F., Groves, M. R., Hiltermann, T. J., van den Berg, A., Groen, H. J. & Schuuring, E., jul.-2017, In: Cancer Research. 77, 2 blz., Abstract 754.

  Onderzoeksoutput › Academic
• 2014

  Everolimus-induced hyperglycemia: Dual efficacy of metformin

  Ariaans, G., De Jong, S., De Vries, E. G. E. & Jalving, M., 1-okt.-2014, In: Cancer Research. 74, 19, Suppl., 1 blz., 4330.

  Onderzoeksoutput › Academic

  • Hyperglycemia 100%
  • Mitochondrial Respiration 100%
  • Glycon 100%
  • Everolimus 100%
  • Metformin 100%
• 2006

  Proton pump inhibitor use is associated with the development of sporadic fundic gland polyps

  Jalving, M., Koornstra, J. J., Wesseling, J. & Kleibeuker, J. H., apr.-2006, In: Gastroenterology. 130, 4, blz. A69-A69 1 blz.

  Onderzoeksoutput › Academic
• 2004

  TRAIL receptor expression in hereditary and sporadic colorectal tumors as targets for apoptosis induction and the role of BAX mutations as an evading mechanism

  Koornstra, J., Jalving, M., Rijcken, F., Westra, J., Zwart, N., Hollema, H., de Vries, E., Hofstra, R., Kleibeuker, J. & de Jong, S., apr.-2004, In: Gastroenterology. 126, 4, blz. A273-A273 1 blz.

  Onderzoeksoutput › Academic